Search research articles
Contact Us
Filters
Showing results (161-170 of 164) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 164 results.
Brain Communications
|
October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae
Léo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
BMC Systems Biology
|
July 5, 2011
Construction of a computable cell proliferation network focused on non-diseased lung cells
Jurjen W Westra, Walter K Schlage, Brian P Frushour, et al.
ESMO Open
|
January 21, 2026
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer
E J van Dijk, M M Smeenk, F Bensch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2024
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
Rik J Verheijden, Femke H Burgers, Josephine C Janssen, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 164) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 164 results.
Brain Communications
|
October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae
Léo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
BMC Systems Biology
|
July 5, 2011
Construction of a computable cell proliferation network focused on non-diseased lung cells
Jurjen W Westra, Walter K Schlage, Brian P Frushour, et al.
ESMO Open
|
January 21, 2026
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer
E J van Dijk, M M Smeenk, F Bensch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2024
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
Rik J Verheijden, Femke H Burgers, Josephine C Janssen, et al.
Page
of 17